Role of complement in patients with autoimmune hemolytic anemia and platelet transfusion refractoriness

被引:0
|
作者
Fontaine, Magali J. [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Pathol, 22 S Greene St N2W50a, Baltimore, MD 21201 USA
关键词
Complement; Hemolysis; Autoimmune; Platelet transfusion refractoriness; HLA ANTIBODIES; IMMUNE; ALLOIMMUNIZATION; AUTOANTIBODIES; MANAGEMENT; MECHANISMS; FAILURE; BLOOD;
D O I
10.1016/j.tracli.2019.06.232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The complement is a key player of the innate immune response. It provides defense mechanisms that are not specific, but very efficient at neutralizing any invader, accounting for 4% of the proteins in the peripheral blood. Nevertheless, there is a dark side to the complement system, as it may activate its machinery against healthy cells such as peripheral blood red blood cells and platelets resulting in undesired hemolysis and thrombocytopenia, respectively. Understanding and identifying the role of complement in these settings allow physicians to adjust their diagnostic and therapeutic modalities accordingly. The role of complement in the pathophysiology and management of autoimmune hemolytic anemia and of alloimmune-mediated thrombocytopenia is under investigation and discussed. (C) 2019 Societe francaise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:152 / 154
页数:3
相关论文
共 50 条
  • [41] SIGNIFICANCE OF COMPLEMENT ACTIVATION IN AUTOIMMUNE HEMOLYTIC-ANEMIA OF WARM TYPE
    KRETSCHMER, V
    MUELLERECKHARDT, C
    BLUT, 1977, 35 (06): : 447 - 455
  • [42] The treatment of autoimmune hemolytic anemia with complement inhibitor iptacopan: a case report
    Li, Xiaoqing
    Zhou, Minran
    Ma, Sai
    Wang, Ran
    Zhao, Chuanli
    Chen, Chunyan
    FRONTIERS IN MEDICINE, 2025, 12
  • [43] Rituximab in patients with refractory autoimmune hemolytic anemia
    Dierickx, Daan
    Verhoef, Gregor
    Delannoy, Andre
    ANNALS OF HEMATOLOGY, 2011, 90 (08) : 985 - 986
  • [44] AUTOIMMUNE HEMOLYTIC ANEMIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
    Simonovic, E.
    Macukanovic-Golubovic, L.
    Colic, V.
    HAEMATOLOGICA, 2014, 99 : 592 - 593
  • [45] Metabolomic Profile in Patients with Autoimmune Hemolytic Anemia
    Rabelo, Iara Baldim
    Chiba, Akemi Kuroda
    Moritz, Elyse
    Barros, Melca Oliveira
    Cotrim Guerreiro Silva, Ismael Dale
    Bordin, Jose Orlando
    Chauffaille, Maria de Lourdes
    Yamamoto, Mihoko
    Arrais, Celso
    BLOOD, 2018, 132
  • [46] Severe hypogammaglobulinemia in patients with autoimmune hemolytic anemia
    Carbone, J.
    Sarmiento, E.
    del Toro, J.
    Escudero, A.
    REVISTA CLINICA ESPANOLA, 2007, 207 (05): : 266 - 268
  • [47] Cytokine polymorphisms in patients with autoimmune hemolytic anemia
    Zaninoni, Anna
    Fattizzo, Bruno
    Pettine, Loredana
    Vercellati, Cristina
    Marcello, Anna P.
    Barcellini, Wilma
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Cryptococcal Meningitis in Patients with Autoimmune Hemolytic Anemia
    Yang, YaLi
    Sang, Junjun
    Pan, Weihua
    Du, Lin
    Liao, Wanqing
    Chen, Jianghan
    Zhu, Yuanjie
    MYCOPATHOLOGIA, 2014, 178 (1-2) : 63 - 70
  • [49] Rituximab in patients with refractory autoimmune hemolytic anemia
    Daan Dierickx
    Gregor Verhoef
    André Delannoy
    Annals of Hematology, 2011, 90 : 985 - 986
  • [50] TRANSFUSING PATIENTS WITH AUTOIMMUNE HEMOLYTIC-ANEMIA
    GARRATTY, G
    PETZ, LD
    LANCET, 1993, 341 (8854): : 1220 - 1220